About | Free Trial

Last Update

2016-05-17T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Wrong Kate Bingham?

Dr. Kate Bingham

Managing Partner

Schroder Ventures Life Sciences

Direct Phone: +44 **********       

Email: k***@***.com

Schroder Ventures Life Sciences

60 State Street Suite 3650

Boston, Massachusetts 02109

United States

Company Description

Schroder Ventures Life Sciences ("SVLS") has a team of 22 professionals based in London and Boston with a deep base of life sciences investment, operational, scientific and clinical experience. Schroder Ventures' funds have invested in the life sciences i ... more

Find other employees at this company (7)

Background Information

Employment History

Partner
SNR Denton

Head of Technology Media and Telecoms Department
Dentons

Affiliations

Board Member
Pulmocide LTD

Investment Committee As Well As the Investment Committees
DDF

Board Member
Bicycle Therapeutics Limited

Council Member
British Venture Capital Association

Board Member
RespiVert LTD

Member, S Supervisory Board
Ingenium Pharmaceuticals GmbH

Education


Biochemistry
Oxford University

MBA

Harvard Business School

Masters degree
Biochemistry
Oxford University

first class Masters degree
Biochemistry
University Oxford

first class degree
Biochemistry
Oxford University

Web References (166 Total References)


Kate ...

pulmocide.com [cached]

Kate Bingham

Kate is Managing Partner at SVLS and is based in London.
Kate currently serves or has served on the boards of companies in the UK, US, Ireland, Sweden and Germany. She has been responsible for past investments in Affinium, Alantos, Auxilium, Convergence, ESBATech, EUSA, Hexagen, Kinetix, KuDOS, Leukosite, MedNova, Micromet, Oncoethix, PowderMed, RespiVert and Vantia and current investments including Atopix, Autifony, Bicycle, Calchan, Kalvista, Karus, Kesios, Pulmocide, TopiVert and VHSquared. Kate has played an active role in setting up the new Dementia Discovery Fund (DDF) and serves on the DDF Investment Committee as well as the Investment Committees for all SV's funds. Prior to joining SVLS, Kate worked in business development for Vertex Pharmaceuticals, a biotechnology company in Cambridge, MA and at Monitor Company, a strategy consulting firm. Kate has a first class degree in Biochemistry from Oxford University and graduated from Harvard Business School with an MBA (Baker Scholar).


LifeSci has met with SV Life ...

www.biospace.com [cached]

LifeSci has met with SV Life Sciences Managing Partner Kate Bingham and BioCentury Co-Founder & Chairwoman Karen Bernstein, the co-authors of an open letter that criticized the company’s January event, as well as well-known industry leaders, CEOs, management teams, boards of directors, members of the media, leading diversity advocates in the life sciences field and clients throughout the U.S., Europe and Israel to determine concrete steps for moving forward.

...
The board will be co-chaired by Knightsbridge Advisers Managing Principal Barbara Piette and Stem for Life Foundation Founder Robin Smith, MD MBA, and includes other industry leaders Renee Gala, CFO, Theravance Biopharma, Annalisa Jenkins MBBS MRCP, President and CEO of Dimension Therapeutics, and Kate Bingham, Managing Partner at SV Life Sciences, among others.


LifeSci met with the authors ...

www.biospace.com [cached]

LifeSci met with the authors of the critical letter, Kate Bingham, a managing partner of SV Life Sciences, and “BioCentury� co-founder Karen Bernstein, to discuss its proposed initiatives.


LifeSci met with the authors ...

www.biospace.com [cached]

LifeSci met with the authors of the critical letter, Kate Bingham, a managing partner of SV Life Sciences, and “BioCentury� co-founder Karen Bernstein, to discuss its proposed initiatives.


LifeSci has met with SV Life ...

www.biospace.com [cached]

LifeSci has met with SV Life Sciences Managing Partner Kate Bingham and BioCentury Co-Founder & Chairwoman Karen Bernstein, the co-authors of an open letter that criticized the company’s January event, as well as well-known industry leaders, CEOs, management teams, boards of directors, members of the media, leading diversity advocates in the life sciences field and clients throughout the U.S., Europe and Israel to determine concrete steps for moving forward.

...
The board will be co-chaired by Knightsbridge Advisers Managing Principal Barbara Piette and Stem for Life Foundation Founder Robin Smith, MD MBA, and includes other industry leaders Renee Gala, CFO, Theravance Biopharma, Annalisa Jenkins MBBS MRCP, President and CEO of Dimension Therapeutics, and Kate Bingham, Managing Partner at SV Life Sciences, among others.

Similar Profiles

Other People with this Name

Other people with the name Bingham

Monique Bingham
Dunn Easy

Emily Bingham
Wright State Alumni

Glenda Bingham
R L H Agency Llc

Bridget Bingham
National Cattlemen's Beef Association

Brady Bingham
Credit Suisse First Boston LLC

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory